Actualités réglementaires25 sept. 2026•1 min de lecture

FDA Marks PANRAY's THEOLIXIR Oral Elixir as Discontinued (ANDA084559)

Par l'équipe PharmaCountry

The FDA’s ANDA084559 filing shows PANRAY’s oral elixir THEOLIXIR, containing THEOPHYLLINE 80MG/15ML, is listed as discontinued.

The U.S. Food and Drug Administration (FDA) has recorded the status of product THEOLIXIR under application number ANDA084559. THEOLIXIR is an oral elixir (route: ORAL) marketed by sponsor PANRAY. The product contains the active ingredient THEOPHYLLINE at a strength of 80 mg per 15 mL. According to the FDA filing, the marketing status of THEOLIXIR is listed as discontinued. No reference drug or reference standard is associated with this filing.

Compilé par l'équipe PharmaCountry · Source : FDA.gov

Sujets :#FDA #ANDA #discontinued #Oral #Theophylline #pharma